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ABSTRACT Recent genome-wide association studies reveal that the FAM13A gene is associ-
ated with human lung function and a variety of lung diseases, including chronic obstructive 
pulmonary disease, asthma, lung cancer, and pulmonary fibrosis. The biological functions of 
Fam13a, however, have not been studied. In an effort to identify novel substrates of B56-
containing PP2As, we found that B56-containing PP2As and Akt act antagonistically to con-
trol reversible phosphorylation of Fam13a on Ser-322. We show that Ser-322 phosphoryla-
tion acts as a molecular switch to control the subcellular distribution of Fam13a. Fam13a 
shuttles between the nucleus and cytoplasm. When Ser-322 is phosphorylated by Akt, the 
binding between Fam13a and 14-3-3 is enhanced, leading to cytoplasmic sequestration of 
Fam13a. B56-containing PP2As dephosphorylate phospho–Ser-322 and promote nuclear lo-
calization of Fam13a. We generated Fam13a-knockout mice. Fam13a-mutant mice are viable 
and healthy, indicating that Fam13a is dispensable for embryonic development and physio-
logical functions in adult animals. Intriguingly, Fam13a has the ability to activate the Wnt 
pathway. Although Wnt signaling remains largely normal in Fam13a-knockout lungs, deple-
tion of Fam13a in human lung cancer cells causes an obvious reduction in Wnt signaling activ-
ity. Our work provides important clues to elucidating the mechanism by which Fam13a may 
contribute to human lung diseases.
INTRODUCTION
Reversible phosphorylation of proteins is a key mechanism that con-
trols the function, localization, and stability of proteins and is impor-
tant for the vast majority of cellular processes. Phosphorylation 
occurs most commonly on serine (Ser) and threonine (Thr) residues 
in proteins. In humans, there are >400 Ser/Thr protein kinases, each 
recognizing and phosphorylating unique motifs in their substrate 
proteins (Manning et al., 2002). Of interest, the human genome con-
tains only a dozen genes that encode catalytic subunits of Ser/Thr 
protein phosphatases, highlighting the importance of these de-
phosphorylating enzymes.
Protein phosphatase 2A (PP2A) is one of the most abundantly 
expressed Ser/Thr protein phosphatases, making up to 0.1% of the 
total cellular protein in most cells. PP2A is a heterotrimer. The ho-
loenzyme is composed of a scaffold (A), a catalytic (C), and a regula-
tory (B) subunit. The B regulatory subunits are important for the sub-
strate specificity, subcellular localization, and activity of the 
holoenzyme (Slupe et al., 2011). Recent studies demonstrate that 
the B56 family of PP2A regulatory subunits (α, β, γ, δ, and ε isoforms) 
are involved in a wide range of biological processes, including cell 
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RESULTS
B56-containing PP2As regulate the subcellular localization 
of Fam13a
To understand better roles of B56-containing PP2As in controlling 
intracellular signaling events, we carried out a yeast two-hybrid 
screen for novel substrates of B56-containing PP2As using B56ε as 
bait. In addition to known substrates of B56-containing PP2As—for 
example, axin (Li et al., 2001) and Dzip1 (Jin et al., 2011)—we identi-
fied Fam13a. Because SNPs in the FAM13A gene are associated 
with multiple human lung diseases (Cho et al., 2010; Hancock et al., 
2010; Pillai et al., 2010; Guo et al., 2011; Li et al., 2011; Young et al., 
2011; Fingerlin et al., 2013), we set out to determine whether 
Fam13a is indeed a substrate of B56-containing PP2As.
We first performed a coimmunoprecipitation in HEK293T cells to 
verify the interaction between Fam13a and B56ε. We were able to 
coimmunoprecipitate FAM13A with B56ε (Figure 1A, left). Con-
versely, B56ε was copurified with Fam13a (Figure 1A, right). As de-
scribed later, we also performed a yeast two-hybrid screen using 
Fam13a as bait. Multiple B56 isoforms, including B56α, B56β, B56γ, 
and B56δ, were retrieved from the screen (unpublished data). Using 
the yeast two-hybrid system, we directly examined the interaction 
between Fam13a and all five B56 family members. Indeed, all B56s 
interacted with Fam13a. According to the growth rate of yeast trans-
formants on selection medium, Fam13a binds B56α, B56β, and 
B56ε with a higher binding affinity (Table 1). We then generated se-
rial deletion constructs of Fam13a and mapped the B56-binding 
domain in Fam13a. As shown in Figure 1B, FLAG-B56ε interacted 
with the full-length and a partially truncated Fam13a (residues 
1–609). In contrast, we failed to detect binding between FLAG-B56ε 
and other truncated forms of Fam13a (1–513, 1–393, 1–341, 1–158). 
Consistently, ∆513-609, a mutant Fam13a lacking residues 513–609, 
failed to interact with FLAG-B56ε. We noticed that 515–609 inter-
acted with B56ε very weakly. In contrast, 460–609 strongly inter-
acted with B56ε (Figure 1B). Thus the sequence between residues 
460 and 609 of Fam13a, which is conserved across species (Supple-
mental Figure S1), is sufficient and necessary for B56 binding.
To address whether PP2A regulates Fam13a, we assessed the 
effect of PP2A inhibition on the subcellular distribution of Fam13a in 
NIH3T3 cells. Myc-Fam13a was enriched in the nucleus in 85% of 
control (dimethyl sulfoxide [DMSO]-treated) NIH3T3 cells. Inhibition 
of PP2A by okadaic acid (OA) treatment altered the subcellular dis-
tribution of Fam13a significantly, with 66% of cells exhibiting cyto-
plasmic Fam13a, ∼31% of cells exhibiting homogeneous distribu-
tion of Fam13a in nuclear and cytosolic compartments, and only 2% 
of cells showing nuclear Fam13a (Figure 1C). The effect of OA on 
subcellular localization of Fam13a was blocked by the nuclear ex-
port inhibitor leptomycin B (Supplemental Figure S2), suggesting 
that OA-induced cytoplasmic localization of Fam13a requires intact 
nuclear export machinery. Of interest, Fam13a contains a putative 
nuclear export signal (NES) sequence (672-IKAKLRLLEVLI-683).
Because Fam13a was originally identified from the screen using 
B56ε as bait, we determined whether knockdown of B56ε was suf-
ficient to alter the subcellular localization of Fam13a. Of interest, 
although the level of endogenous B56ε protein was effectively re-
duced by siB56ε, a small interfering RNA (siRNA) against B56ε 
(Figure 1D), we failed to detect changes in the subcellular distribu-
tion of Fam13a in siB56ε-transfected cells (Figure 1E). This raised 
the possibility that B56-containing PP2As may function redundantly 
to control the subcellular localization of Fam13a.
To study redundant functions of B56 subunits, we performed a 
combinatorial knockdown of all five B56 subunits in the “Aα ex-
change” cell line. Generated from the PC6-3 subline of PC12 cells 
cycle regulation (Foley et al., 2011; Isoda et al., 2011; Chambon 
et al., 2013; Kruse et al., 2013; Porter et al., 2013; Xu et al., 2013), 
apoptosis (Li et al., 2002; Silverstein et al., 2002; Holland et al., 
2007; Ruvolo et al., 2008; Jin et al., 2010), embryonic development 
(Hannus et al., 2002; Yang et al., 2003; Rorick et al., 2007; Jin et al., 
2009, 2011; Varadkar et al., 2014), tumorigenesis (Li et al., 2007; 
Shouse et al., 2008, 2010; Nobumori et al., 2013), and the longevity 
of worms (Padmanabhan et al., 2009). The crystal structure of B56-
containing PP2A has been determined. It has been proposed that 
B56 uses its concave acidic surface to interact with the basic region 
on the substrates (Xu et al., 2006; Cho and Xu, 2007). Only a small 
number of substrates of B56-containing PP2As have been identi-
fied. These substrates are involved in a number of major signaling 
pathways (Virshup and Shenolikar, 2009; Yang and Phiel, 2010). In 
many cases, how dephosphorylation by B56-containing PP2As al-
ters the function of a protein remains elusive.
B56-containing PP2As play important roles in Wnt signaling. The 
canonical Wnt pathway is essential for vertebrate axis specification 
and a variety of developmental processes. It also functions in adult 
stem cells to regulate adult tissue homeostasis. Dysregulated Wnt 
signaling causes severe consequences, ranging from defective em-
bryonic development to tumorigenesis in adult animals (Nusse, 
2008; MacDonald et al., 2009; van Amerongen and Nusse, 2009; 
Clevers and Nusse, 2012). Wnt proteins operate the pathway by 
controlling the stability of β-catenin. In the absence of Wnt, β-catenin 
is phosphorylated by the β-catenin destruction complex, a cytosolic 
multiprotein complex consisting of axin, GSK3, APC, etc. Once 
phosphorylated, β-catenin is rapidly degraded through the ubiqui-
tin/proteasome pathway. Upon binding to their receptors, Wnt pro-
teins initiate an intracellular signaling cascade. Through Dishevelled 
proteins, Wnts prevents phosphorylation of β-catenin, leading to 
accumulation of β-catenin in the nucleus, where it activates down-
stream target genes together with TCF/Lef transcription factors 
(Clevers and Nusse, 2012). B56s can form a complex with axin and 
inhibit Wnt signaling by promoting degradation of β-catenin 
(Seeling et al., 1999; Li et al., 2001). Of interest, knockdown of B56ε, 
which physically interacts with Dishevelled (Ratcliffe et al., 2000), 
interferes with Wnt signaling in Xenopus embryos (Yang et al., 2003; 
Jin et al., 2009). It appears that B56-containing PP2As dephosphor-
ylate several components of the Wnt pathway and play a multifac-
eted role during Wnt signaling.
Results from recent genome-wide association studies (GWASs) 
indicate that genetic variations in the FAM13A gene (Family with 
sequence similarity 13, member A) are associated with human lung 
diseases. Using spirometry measurements as markers for lung func-
tion, several groups independently discovered that a number of in-
tronic single nucleotide polymorphisms (SNPs) in FAM13A are sig-
nificantly associated with human lung function and chronic 
obstructive pulmonary disease (COPD; Cho et al., 2010; Hancock 
et al., 2010; Pillai et al., 2010). Triggered by these finding, FAM13A 
SNPs were tested in other lung diseases. Indeed, an intriguing link 
between FAM13A and asthma severity was identified (Li et al., 
2011). In lung cancer, a SNP of FAM13A, rs7671167, confers a pro-
tective effect, independent of the age, sex, height, lung function, 
and smoking history of the patients (Young et al., 2011). More re-
cently, FAM13A SNPs were found to be associated with pulmonary 
fibrosis (Fingerlin et al., 2013). In the case of COPD, the FAM13A 
risk SNP rs2609261 is associated with elevated expression of 
FAM13A in the lung (Kim et al., 2014). These findings suggest that 
altered expression of Fam13a may contribute to human lung patho-
logical conditions. Nevertheless, the biological function of Fam13a 
has not been studied.
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Because free B56 subunits are rapidly degraded through the ubiq-
uitin/proteasome pathway, doxycycline treatment leads to deple-
tion of all B56 isoforms without affecting levels of other PP2A regu-
latory subunits (Strack et al., 2004). In control cells (Aα WT), 
doxycycline treatment has no effect on B56 subunit levels because 
endogenous PP2A A subunit is replaced by a wild-type A subunit, 
(Pittman et al., 1993), Aα exchange cells express both short hairpin 
RNA (shRNA), which targets the endogenous Aα subunit, and 
shRNA-resistant mutant Aα from doxycycline-inducible promoters. 
In Aα exchange cells, doxycycline treatment triggers replacement 
of the endogenous scaffolding subunit with an Aα mutant 
(DTP177AAA; Ruediger et al., 1999) that cannot bind B56 subunits. 
FIGURE 1: B56-containing PP2As regulate nuclear localization of Fam13a. (A) Coimmunoprecipitation (CoIP) showing 
the interaction between FAM13A and B56ε. B56ε-FLAG and myc-FAM13A were expressed in HEK293T cells alone or in 
combination. Cells were harvested and subjected to CoIP with an anti-FLAG antibody (left) or an anti-myc antibody 
(right). (B) Western blot showing that FLAG-B56ε coimmunoprecipitated with full-length Fam13a and 1–609 but not 
other Fam13a deletion constructs (1–513, 1–393, 1–341, 1–158, and ∆513x609). In addition, FLAG-B56ε strongly 
interacted with 460–609 but only very weakly with 513–609 and 513–693. (C) Immunofluorescence images showing the 
nuclear localization of Fam13a in control (DMSO) cells and cytoplasmic localization of Fam13a in OA-treated cells. 
(D) Western blot showing knockdown of endogenous B56ε by a siRNA against B56ε (siB56ε). (E) Immunofluorescence 
images showing the nuclear localization of Fam13a in control (siGFP) and B56ε knockdown (siB56ε) cells. 
(F) Immunofluorescence images showing subcellular localization of wild-type Fam13a in vehicle or doxycycline-treated 
Aα exchange cells. Wild-type Fam13a was nuclear in vehicle-treated DTP177AAA and AαWT cells. Doxycycline 
treatment induced cytoplasmic sequestration of Fam13a in DTP177AAA cells but not in AαWT cells. Shown in 
C, E, and F are representative staining patterns. The percentage of cells displaying nuclear (N), cytoplasmic (C), or even 
distribution between nucleus and cytoplasm (N = C) are graphed. At least 100 cells from each sample were scored in 
each experiment. (G) Fractionation of control (DMSO-treated) and OA-treated A549 cells. Endogenous Fam13a protein 
in nuclear and cytosolic fractions was analyzed by Western blot. β-Tubulin and C/EBPβ served as marker for cytosolic 
and nuclear fractions, respectively.
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We further extended our analysis by determining if PP2A regu-
lates the nuclear localization of endogenous Fam13a. Because the 
anti-Fam13a antibody showed high background in immunostaining, 
we fractionated A549 human lung cancer cells, in which endoge-
nous Fam13a protein can be detected by Western blot analysis 
(Supplemental Figure S3). In control A549 cells, Fam13a protein was 
detected in both cytosolic and nuclear fractions. Inhibition of PP2As 
by OA treatment increased the amount of cytosolic Fam13a and 
decreased the amount of nuclear Fam13a (Figure 1G). Taking the 
results collectively, we conclude that B56-containing PP2As are re-
quired for the nuclear localization of Fam13a.
Identification of nuclear localization signals in Fam13a
Using a Web-based nuclear localization signal (NLS) prediction 
program, we found two arginine/lysine-rich putative NLSs (residues 
335–341 and 527–536) in Fam13a protein. To determine whether 
these putative NLSs sequences are indeed required for the nuclear 
localization of Fam13a, we mutated these putative NLSs individu-
ally (RR340AA and RR531AA) and in combination (RR340;531AA; 
Figure 2A). The subcellular localization of these constructs was as-
sessed in NIH3T3 cells by immunostaining. As shown earlier, wild-
type Fam13a was enriched in the nucleus. In contrast, all three 
mutants were mislocalized, with the majority of transfected cells 
(67% of RR340AA, 81% of RR531AA, and 79% of RR340;531AA) 
exhibiting homogeneous distribution or cytoplasmic accumulation 
of Fam13a (Figure 2B). These results demonstrate that both NLSs 
are required for the nuclear localization of Fam13a.
Fam13a interacts with 14-3-3
To gain insights into the function and/or regulation of Fam13a, we 
carried out a yeast two-hybrid screen for Fam13a-binding proteins 
using the full-length Fam13a as bait. Apart from several B56 iso-
forms, >70% of clones identified from this screen carry cDNAs en-
coding 14-3-3 proteins, including η, ε, ζ, and θ isoforms.
14-3-3 isoforms are highly conserved proteins involved in a wide 
range of biological processes. In many cases, 14-3-3 proteins se-
quester their ligands in the cytoplasm. It is also known that binding 
of 14-3-3 to their ligands requires phosphorylation of a Ser/Thr resi-
due located in the center of the 14-3-3 binding motif (Muslin and 
Xing, 2000; Aitken, 2006; Freeman and Morrison, 2011; Reinhardt 
and Yaffe, 2013). We thus hypothesized that inhibition of PP2A en-
hances phosphorylation of Fam13a, leading to increased binding 
between Fam13a and 14-3-3. This ultimately results in cytoplasmic 
sequestration of Fam13a.
To test this hypothesis, we first verified the interaction between 
Fam13a and 14-3-3s. In a GST pull-down assay, Fam13a was effi-
ciently pulled down by bacterially expressed GST–14-3-3η and 
GST–14-3-3ε (Figure 3A). When 14-3-3η and Fam13a were coex-
pressed in HEK293T cells, FLAG–14-3-3η and myc-Fam13a coim-
munoprecipitated with each other (Figure 3B). These results suggest 
that Fam13a and 14-3-3 proteins interact directly. We then mapped 
the 14-3-3–binding domain using a GST pull-down assay. The full-
length and most truncated Fam13a (1–609, 1–513, 1–393, 1–341) 
were pulled down by GST–14-3-3. By contrast, 1–158 failed to inter-
act with 14-3-3 (Figure 3C), suggesting that 14-3-3 binds to a do-
main located between residues 158 and 341 in Fam13a. Of interest, 
a putative 14-3-3 binding motif was found between residues 315 
and 329. We generated ∆315–329, a deletion mutant lacking this 
region. Indeed, truncation of residues 315–329 markedly reduced 
the binding between 14-3-3 and Fam13a in a GST pull-down assay 
(Figure 3D). This demonstrates that residues 315–329 are indeed 
important for binding between Fam13a and 14-3-3. Of note, we 
which is capable of binding to B56s (Strack et al., 2004). In Aα 
DTP177AAA exchange cells, Fam13a was predominantly nuclear in 
the majority of cells (Figure 1F). Combinatorial knockdown of all 
B56-containing PP2As by doxycycline treatment induced cytoplas-
mic sequestration of Fam13a, with only 20% of cells showing nuclear 
localization of Fam13a. The majority of doxycycline-treated cells ex-
hibited either cytoplasmic (41%) or homogeneous (38%) distribution 
of Fam13a. Fam13a subcellular distribution remained unaltered in 
control cells (Aα WT) treated with doxycycline (Figure 1F). This indi-
cates that B56-containing PP2As function redundantly to regulate 
the nuclear localization of Fam13a.
FIGURE 2: Identification of NLSs in Fam13a. (A) Schematic diagram 
of wild-type Fam13a and NLS mutants (RR340AA, RR531AA, and 
RR340;531AA). (B) Representative immunofluorescence images 
showing the nuclear localization of wild-type Fam13a and 
mislocalization of NLS mutants in NIH3T3 cells. Bar graphs show 
percentage of cells that exhibit nuclear, cytoplasmic, or homogeneous 
subcellular distribution. R, arginine; A, alanine.
  pGBKT7-Fam13a
pACT2 –
pACT2-B56α ++
pACT2-B56β ++
pACT2-B56δ +
pACT2-B56γ +
pACT2-B56ε ++
Summary of the interaction between B56s and Fam13a in the yeast two-hybrid 
system. The number of plus signs indicates the relative binding affinity, as 
judged by the growth rate of yeast transformants.
TABLE 1: Binding between Fam13a and B56 isoforms.
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interaction between Fam13a and 14-3-3. 
Truncation of residues 315–329 reduced the 
effect of B56s knockdown on the binding 
between Fam13a and 14-3-3 (Figure 4D). 
These results indicate that inhibition of B56-
containing PP2As promotes association of 
Fam13a with 14-3-3 and cytoplasmic se-
questration of Fam13a.
Akt promotes the binding between 
Fam13a and 14-3-3 and cytoplasmic 
sequestration of Fam13a
The 14-3-3 proteins preferentially bind to 
phosphorylated ligands. The 14-3-3 bind-
ing motif of Fam13a (residues 315–329) 
contains a putative Akt recognition motif 
(RXRXXS/T), raising the possibility that Akt 
may phosphorylate Fam13a and regulate 
the subcellular localization of Fam13a by 
controlling its interaction with 14-3-3 pro-
teins. To test this hypothesis, we asked 
whether overexpression of myristoylated-
Akt (Akt-myr), a constitutively active Akt, 
could alter the subcellular localization of 
Fam13a in NIH3T3 cells. We found that 
when expressed alone, Fam13a was local-
ized in the nucleus in the majority of cells. 
Coexpression of Akt-myr significantly al-
tered the localization of Fam13a, with 
∼90% of cells exhibiting either cytoplasmic 
or homogeneous distribution of Fam13a 
(Figure 5A).
Next we asked whether Akt is required 
for cytoplasmic sequestration of Fam13a in 
response to inhibition of B56-containing 
PP2As. Consistent with the foregoing observation, Fam13a was pri-
marily nuclear in control (DMSO-treated) cells. OA treatment in-
duced cytoplasmic sequestration of Fam13a, with ∼90% of cells 
showing either cytoplasmic or homogeneous localization (Figure 
5B). The majority of cells treated with wortmannin or LY294002, two 
compounds that inhibit Akt, showed nuclear localization of Fam13a. 
Strikingly, wortmannin or LY294002 treatment reduced cytoplasmic 
sequestration of Fam13a induced by OA. Nuclear Fam13a was ob-
served in ∼60% of wortmannin/OA- and 85% of LY294002/OA-
treated cells (Figure 5B). This demonstrates that Akt-dependent 
phosphorylation of Fam13a is essential for cytoplasmic sequestra-
tion of Fam13a in response to PP2A inhibition.
To assess directly the effect of Akt inhibition on the binding be-
tween Fam13a and 14-3-3, we again performed a GST pull-down 
assay. As expected, OA treatment strongly enhanced the interaction 
between Fam13a and GST-14-3-3. This OA-induced interaction was 
significantly reduced by wortmannin treatment (Figure 5C). Collec-
tively our results strongly support the hypothesis that Akt triggers 
cytoplasmic sequestration of Fam13a by promoting the interaction 
between Fam13a and 14-3-3 proteins.
Akt and PP2A regulate Ser-322 phosphorylation of Fam13a
Within the 14-3-3 binding motif (residues 315–329), Ser-322 is a pu-
tative Akt site. To determine whether Akt and PP2A regulate 
Fam13a/14-3-3 binding and subcellular localization of Fam13a at 
least in part by controlling phosphorylation on Ser-322, we blocked 
Ser-322 phosphorylation by substitution to Ala (S322A). We first 
detected a very weak but reproducible interaction between ∆315–
329 and 14-3-3. Our results indicate that Fam13a contains another 
14-3-3 binding motif, which is located between residues 404 and 
418. Mutation of this 14-3-3 binding motif completely abolished the 
interaction between ∆315–329 and 14-3-3 (Supplemental Figure 
S4), indicating that residues 404–418 are responsible for the weak 
binding between ∆315–329 and 14-3-3.
Next we asked whether residues 315–329, which are important 
for 14-3-3 binding, are required for cytoplasmic sequestration of 
Fam13a in response to PP2A inhibition. In control (DMSO-treated) 
NIH3T3 cells, both ∆315–329 and Fam13a were predominantly nu-
clear. OA treatment induced cytoplasmic sequestration of Fam13a. 
In contrast, ∆315–329 remained in the nucleus in the majority of OA-
treated cells (61%; Figure 4A). To implicate B56 subunits, we again 
used Aα DTP177AAA exchange cells. Consistently, depletion of 
B56-containing PP2As by doxycycline treatment induced cytoplas-
mic sequestration of wild-type Fam13a but had only minimal effect 
on ∆315–329 (Figure 4B). These results indicate that the 14-3-3 
binding domain (residues 315–329) is required for cytoplasmic se-
questration of Fam13a upon inhibition of B56-containing PP2As.
Parallel to the foregoing analyses, we assessed the effects of 
PP2A inhibition and B56s depletion on the interaction between 
Fam13a and 14-3-3. We found that OA treatment markedly en-
hanced the binding between Fam13a and 14-3-3. The effect of OA 
on this biochemical interaction was reduced significantly by trunca-
tion of residues 315–329 (Figure 4C). Consistently, depletion of 
B56-containing PP2As by doxycycline treatment promoted the 
FIGURE 3: Interaction between Fam13a and 14-3-3. (A) GST pull down, showing that Fam13a 
interacted with bacterially expressed GST–14-3-3η and GST–14-3-3ε but not GST. (B) Western 
blot, showing coimmunoprecipitation of myc-Fam13a and FLAG–14-3-3η. FLAG–14-3-3η was 
detected when myc-Fam13a was immunoprecipitated (middle). Conversely, myc-Fam13a was 
detected when FLAG-14-3-3η was immunoprecipitated (right). (C) GST pull-down assay, showing 
that GST–14-3-3 interacts with the full-length Fam13a and some Fam13a deletion constructs 
(1–609, 1–513, 1–393, and 1–341). GST-14-3-3 failed to pull down 1–158. (D) Western blot, 
showing that truncation of residues 315–329 decreased the binding between GST–14-3-3 and 
Fam13a.
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phosphorylated on Ser-322. This antibody recognizes the wild-type 
Fam13a but not ∆315–329. It reacted to S322A weakly (Figure 6C). 
Thus this antibody preferentially recognizes Fam13a that is phos-
phorylated on Ser-322 (pS322). Using this antibody, we examined 
the effects of Akt and PP2A on Ser-322 phosphorylation. As shown 
in Figure 6D, we were able to detect a low level of pSer-322 in 
DMSO-treated control cells. Inhibition of PP2A by OA caused a ro-
bust increase in Ser-322 phosphorylation. Inhibition of Akt by treat-
ing cells with wortmannin caused a moderate decrease in Ser-322 
phosphorylation. When cells were treated with OA and wortmannin, 
Ser-322 phosphorylation induced by OA was blunted by wortman-
nin. We also examined the effects of B56s overexpression on Ser-
322 phosphorylation. We found that overexpression of B56β, B56γ, 
B56δ, and B56ε resulted in a decrease in Ser-322 phosphorylation 
(Figure 6E), further supporting our conclusion that B56-containing 
PP2As function redundantly to dephosphorylate Fam13a. Taken to-
gether, the foregoing results demonstrate that Ser-322 phosphory-
lation, which is important for binding between Fam13a and 14-3-3 
proteins and cytoplasmic sequestration of Fam13a in response to 
PP2A inhibition, is indeed controlled by the antagonistic action of 
Akt and B56-containing PP2As.
assessed the subcellular distribution of S322A. Like the wild-type 
protein, S322A was detected in the nucleus in the majority of cells. 
When Fam13a- expressing cells were treated with OA, ∼70% of cells 
showed cytoplasmic Fam13a, and the other 30% of cells exhibited 
homogeneous distribution of Fam13a between the nucleus and cy-
toplasm. When S322A-expressing cells were treated with OA, only 
∼15% of cells exhibited predominantly cytosolic localization; the re-
mainder showed either mostly nuclear (∼20%) or homogeneous 
(∼65%) localization of the mutant (Figure 6A). We also assessed the 
binding between S322A and 14-3-3 by GST pull-down assays. We 
detected weak binding between Fam13a and 14-3-3. By contrast, 
we failed to detect interaction between S322A and 14-3-3. Inhibi-
tion of PP2A by OA treatment caused a dramatic increase in the 
binding between Fam13a and 14-3-3. When S322A-expressing cells 
were treated with OA, only a small amount of S322A was pulled 
down by GST-14-3-3 (Figure 6B). These results suggest that phos-
phorylation of Fam13a at Ser-322 is important for the binding be-
tween Fam13a and 14-3-3 proteins and cytoplasmic sequestration 
of Fam13a in response to PP2A inhibition.
To assess directly the effects of Akt and PP2A on Ser-322 
phosphorylation, we generated an antibody using a peptide that is 
FIGURE 4: The 14-3-3 binding domain is important for cytoplasmic sequestration of Fam13a in response to PP2A 
inhibition. (A) Representative immunofluorescence images, showing the subcellular distribution of Fam13a and 
∆315–329 in control (DMSO) and OA-treated NIH3T3 cells. Fam13a and ∆315–329 were primarily nuclear in control 
(DMSO) NIH3T3 cells. OA treatment induced cytoplasmic localization of Fam13a. ∆315–329 remained nuclear in the 
majority of OA-treated cells. (B) Representative immunofluorescence images, showing subcellular distribution of 
Fam13a and ∆315–329 in control (vehicle-treated) and doxycycline-treated Aα exchange (DTP177AAA) cells. Fam13a 
and ∆315–329 were nuclear in vehicle-treated cells. After doxycycline treatment, Fam13a was mislocalized. ∆315–329 
remained nuclear in the majority of treated cells. Bar graphs in A and B indicate the percentage of cells that exhibit 
nuclear, cytoplasmic, or homogeneous subcellular distribution. (C) The 14-3-3 binding motif (residues 315–329) is 
required for the effect of PP2A inhibition on binding between Fam13a and bacterially expressed GST–14-3-3η in a GST 
pull-down assay. Fam13a- and ∆315–329–expressing cells were treated with DMSO or OA. Cell lysates were used for 
the GST pull-down assay. Note that OA treatment significantly enhanced interaction between Fam13a and GST–14-3-3. 
Compared to wild-type Fam13a, ∆315-329 showed much weaker interaction with 14-3-3 after OA treatment. (D) The 
14-3-3 binding motif (residues 315–329) is required for the effect of B56s knockdown on binding between Fam13a and 
GST–14-3-3 in a GST pull-down assay. Fam13a- and ∆315–329–expressing Aα exchange cells were treated with vehicle 
or doxycycline. Cell lysates were used in a GST pull-down assay. Doxycycline treatment significantly enhanced the 
interaction between Fam13a and 14-3-3. However, ∆315–329 showed weaker interaction with 14-3-3 compared with 
wild-type Fam13a after doxycycline treatment.
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Fam13a induced axis duplication and in-
creased the expression of Xnr3 and siamois, 
which are direct targets of Wnt signaling 
(Lemaire et al., 1995; Smith et al., 1995; 
Brannon et al., 1997; McKendry et al., 1997), 
suggests that Fam13a has the ability to acti-
vate the Wnt pathway in Xenopus embryos. 
To test this hypothesis, we performed ani-
mal cap assays. As expected, overexpres-
sion of Fam13a induced the expression of 
Xnr3 and siamois in animal caps. Fam13a-
induced expression of Xnr3 and siamois was 
not sensitive to Xdd1, a dominant-negative 
Dishevelled that inhibits the Wnt pathway 
upstream of the β-catenin destruction com-
plex (Sokol, 1996), but was blocked by axin 
and GSK3ß, two factors triggering degrada-
tion of β-catenin. Overexpression of BMP4, 
which regulates vertebrate axis specification 
downstream of the Wnt/siamois cascade, 
did not alter Fam13a-induced expression of 
Xnr3 and siamois (Figure 7C). Consistently, 
we found that overexpression of Fam13a in-
creased the expression of β-catenin protein 
(Figure 7D). It appears that overexpression 
of Fam13a in Xenopus embryos activates 
the Wnt pathway by stabilizing β-catenin.
Because Fam13a shuttles between the 
nucleus and cytoplasm, we extended our 
analysis by determining whether appropri-
ate subcellular localization of Fam13a is im-
portant for its function in the Wnt pathway. 
Thus we compared the activities of Fam13a, 
∆315–329, and RR340;531AA in the animal 
cap assay. The NLS mutant RR340;531AA is 
homogeneously distributed between the 
nucleus and cytoplasm (Figure 2). ∆315–329 
lacks the 14-3-3 binding domain and is pre-
dominantly nuclear even when PP2A is in-
hibited (Figure 4). As shown in Figure 7E, we 
found that overexpression of the wild-type 
Fam13a or ∆315–329 induced the expres-
sion of Xnr3 and siamois. In contrast, 
RR340;531AA showed a very weak activity 
in this assay. This indicates that Fam13a 
functions in the nucleus to activate Wnt 
signaling.
Because Fam13a has been linked to human lung diseases, we 
determined whether Fam13a could activate Wnt signaling in A549 
cells, a widely used human pulmonary epithelial cell model (Giard 
et al., 1973). As shown in Figure 7F, overexpression of Fam13a in-
creased the expression of β-catenin in A549 cells. Consistently, 
Fam13a activates TOPFlash, a Wnt-responsive luciferase reporter, 
and synergizes with β-catenin in the TOPFlash luciferase assay 
(Figure 7G). Similar to the results obtained from Xenopus embryos, 
the NLS mutant RR340;531AA shows a markedly reduced activity in 
the TOPFlash assay in A549 cells (Figure 7H). Thus nuclear localiza-
tion of Fam13a is important for the function of Fam13a in Wnt sig-
naling in human lung cancer cell as well.
Degradation of β-catenin occurs in the cytoplasm (MacDonald 
et al., 2009; Clevers and Nusse, 2012). The finding that Fam13a 
functions in the nucleus to activate Wnt signaling suggests that 
Overexpression of Fam13a activates Wnt signaling
To gain insights into the biological function of Fam13a, we carried out 
gain-of-function studies in Xenopus embryos. We found that injec-
tion of RNA encoding Fam13a (1 ng) into Xenopus embryos induced 
the formation of partial secondary axes (48%, n = 52; Figure 7A). We 
harvested embryos at the gastrula stage (stage 11) and performed 
gene expression analysis. We found that overexpression of Fam13a 
increased the expression of dorsal markers, including siamois, Xnr3, 
chordin, and noggin. The expression of ventral marker sizzled was 
down-regulated. Overexpression of Fam13a had no effect on the 
expression of sox17, a pan-endoderm marker, and Xbra, a pan-meso-
derm marker (Figure 7B). These results indicate that Fam13a is ca-
pable of inducing secondary axis in Xenopus embryos.
Wnt signaling plays essential roles during vertebrate axis specifi-
cation (Heasman, 2006). The observation that overexpression of 
FIGURE 5: Akt promotes cytoplasmic sequestration of Fam13a and binding between Fam13a 
and 14-3-3. (A) Representative immunofluorescence images, showing the subcellular distribution 
of Fam13a when cotransfected with an empty vector or Akt-myr in NIH3T3 cells. 
(B) Representative immunofluorescence images, showing subcellular localization of Fam13a in 
NIH3T3 cells treated with DMSO (control), OA, wortmannin, LY294002, OA plus wortmannin, or 
OA plus LY294002. Fam13a localized in the nucleus in control (DMSO) cells. OA-treated cells 
exhibited cytoplasmic localization of Fam13a. Fam13a remained in the nucleus in wortmannin, 
LY294002-, OA/wortmannin-, or OA/LY294002-treated cells. Bar graphs in A and B indicate the 
percentage of cells that exhibit nuclear, cytoplasmic, or homogeneous subcellular distribution. 
(C) Inhibition of Akt activation by wortmannin reduces OA-induced binding between Fam13a 
and 14-3-3 in a GST pull-down assay. Fam13a-expressing NIH3T3 cells were treated with DMSO 
(control), OA, wortmannin, or OA plus wortmannin. Cell lysates were used in a GST pull-down 
assay. OA treatment strongly enhanced the binding between Fam13a and GST–14-3-3. This 
effect of OA treatment was reduced by wortmannin treatment. Wortmannin treatment itself had 
minimal effect on the binding between Fam13a and GST-14-3-3.
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As the first step toward understanding functions of Fam13a in mam-
mals, we analyzed the expression of FAM13A in adult mouse tissues 
by reverse transcription PCR (RT-PCR). Expression of FAM13A was 
detected in all analyzed tissues, except spleen (Figure 8A). We then 
generated a FAM13A floxed allele in which exon5 of the FAM13A 
gene was flanked by LoxP sites. After breeding FAM13A floxed mice 
with Sox2-Cre mice, we converted the FAM13A floxed allele into a 
FAM13A-knockout allele (Figure 8B). After intercrossing FAM13A 
heterozygous mice, we obtained homozygous FAM13A mutants 
(Figure 8C). These mutants were born at Mendelian ratio and ap-
peared morphologically indistinguishable from their littermates. We 
extracted RNA from the lungs of wild-type, heterozygous, and ho-
mozygous mice and performed RT-PCR. FAM13A was detected at 
their expected sizes in the FAM13A+/+, FAM13A+/−, and FAM13A−/− 
lungs (Figure 8D). We sequenced the PCR product and verified that 
exon 5 was indeed deleted in the FAM13A−/− mutant (Figure 8E). 
Deletion of exon 5 results in a frameshift, leading to truncation of 
Fam13a likely stabilizes β-catenin through an indirect mechanism. 
To gain further insights into the molecular mechanism through which 
Fam13a regulates ß-catenin, we examined the binding between 
Fam13a and some components of the β-catenin destruction com-
plex, including GSK3ß and axin. Our results indicate that FLAG-
Fam13a forms a complex with myc-axin. In contrast, we failed to 
detect an interaction between Fam13a and myc-GSK3β (Figure 7I). 
This indicates that Fam13a is unlikely a component of the β-catenin 
destruction complex. Strikingly, we found that overexpression of 
Fam13a decreased the expression of overexpressed HA-axin pro-
tein (Figure 7J). It appears that overexpression of Fam13a promotes 
turnover of axin protein, which leads to stabilization of β-catenin.
Generation of Fam13a-knockout mice
The FAM13A gene is associated with a number of human lung dis-
eases (Cho et al., 2010; Hancock et al., 2010; Pillai et al., 2010; Guo 
et al., 2011; Li et al., 2011; Young et al., 2011; Fingerlin et al., 2013). 
FIGURE 6: Ser-322 is important for subcellular distribution of Fam13a and its interaction with 14-3-3. (A) Representative 
immunofluorescence images, showing the subcellular distribution of Fam13a and S322A in NIH3T3 cells treated with 
DMSO (control) or OA. Bar graph indicates the percentage of cells that exhibit nuclear, cytoplasmic, or homogeneous 
subcellular distribution. (B) A GST pull down, showing that Ser-322 is important for the binding between Fam13a and 
14-3-3 and the effect of OA on this interaction. Fam13a- and S322A-expressing NIH3T3 cells were treated with DMSO 
(control) or OA. Cell lysates were used in a GST pull-down assay. Interaction between Fam13a and 14-3-3 was markedly 
enhanced in OA-treated cells. In contrast, S322A mutant showed weaker interaction with 14-3-3 in OA-treated cells. 
(C) Western blot, showing the specificity of the anti-phosphoS322 (pS322) antibody. Note that the anti-pS322 antibody 
strongly reacted with Fam13a. It did not react with ∆315–329 but recognized S322A weakly. (D) Western blot, showing 
Ser-322 phosphorylation in NIH3T3 cells treated with DMSO (control), OA, wortmannin, or OA plus wortmannin. pS322 
level was increased by OA treatment. The effect of OA on pS322 was reduced by wortmannin treatment. (E) Western 
blot, showing that overexpression of B56β, B56γ, B56δ, and B56ε decreased Ser-322 phosphorylation. All B56 
expression constructs were FLAG tagged.
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FIGURE 7: Activation of Wnt signaling by Fam13a. (A) Morphology of uninjected and Fam13a RNA (1 ng)–injected 
Xenopus embryos at the tadpole stage. Embryos injected with Fam13a developed partial secondary axes (arrowheads). 
(B) Expression of siamois, Xnr3, chordin, noggin, sizzled, sox17, and Xbra in control and Fam13a-injected embryos. 
Embryos were harvested at the early gastrula stage. (C) Epistasis analysis showing that the expression of siamois and 
Xnr3 in Fam13a-overexpressed animal caps was blocked by coexpression of axin or GSK3ß. (D) Western blot showing 
that overexpression of Fam13a increased the expression of myc–β-catenin in Xenopus embryos. At the two-cell stage, 
embryos were injected with a mixture of myc–β-catenin (100 pg) and myc-GFP (50 pg) RNAs or a mixture of myc–β-
catenin, myc-GFP, and myc-Fam13a (1 ng). Embryos were harvested at stage 9. (E) RT-PCR, showing the expression of 
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axin2 mRNA (Figure 8G). This observation, together with the fact that 
FAM13A−/−-mutant mice are morphologically indistinguishable from 
their littermates, suggests that Fam13a is not essential for Wnt sig-
naling under normal conditions. Of interest, elevated Wnt signaling 
has been observed in A549 and other human lung cancer cells (You 
et al., 2004). It has been reported that activation of Wnt signaling 
accelerates lung tumor growth in transgenic mice carrying an onco-
genic Kras (Sidhu et al., 2010). We thus asked whether Fam13a con-
tributes to elevated Wnt signaling in human lung cancer cells. 
Indeed, we found that knockdown of Fam13a caused a much more 
obvious reduction in the expression of axin2 in A549 cells (Figure 8H). 
Fam13a protein after amino acid residue 97. Given that the FAM13A 
gene is associated with multiple human lung diseases, we examined 
the lungs from adult FAM13A−/− mutants and their wild-type litter-
mates. We failed to detect any morphological difference between 
the wild-type and FAM13A−/−-mutant lungs (Figure 8F). Thus Fam13a 
is dispensable for embryonic and postnatal lung development.
Because overexpression of Fam13a activates the Wnt pathway, 
we also assessed Wnt signaling activities in the control and Fam13a-
knockout lungs by examining the transcription of Axin2, which is 
directly regulated by Wnt signaling (Jho et al., 2002). We found that 
FAM13A−/− lung exhibited a very subtle reduction in the level of 
FIGURE 8: Generation and analysis of Fam13a-knockout mice. (A) RT-PCR, showing the expression of FAM13A in adult 
mouse tissues. (B) Schematic diagram showing the knockout strategy. Arrowheads indicate primers used for 
genotyping. KO-F and GT-B were used to detect the knockout allele (KO). WT-F and GT-B were used to detect the 
wild-type allele (WT). (C) Genotyping PCR showing the genotype of offspring from intercrossing between Fam13a+/− 
mice. (D) RT-PCR, showing the expression of Fam13a in wild-type, heterozygous, and knockout animals. (E) Sequence of 
the PCR product amplified from a Fam13a−/−-knockout animal, showing deletion of exon 5. (F) Histological analysis of 
the large airways (left) and alveoli (right) in a wild-type mouse and a FAM13A-knockout mouse. (G) Representative 
real-time RT-PCR result, showing the levels of axin2 mRNA in control and Fam13a−/− lungs. (H) Representative real-time 
RT-PCR result, showing that knockdown of Fam13a reduced the level of axin2 mRNA in A549 cells.
siamois and Xnr3 in Fam13a-, ∆315–329–, or RR340;531AA-overexpressed animal caps. As a control, the levels of 
injected Fam13a, ∆315-329, and RR340;531AA RNAs were monitored. (F) Western blot, showing that overexpression of 
Fam13a increased the expression of myc–β-catenin in A549 cells. (G) Dual-luciferase assays, showing that 
overexpression of Fam13a activated TOPFlash and enhanced the activity of β-catenin in A549 cells. FOPFlash, which 
contains mutations in the TCF binding sites, was included as a negative control. Firefly luciferase activity was normalized 
to the activity of Renilla luciferase (TK-RL). (H) Overexpression of Fam13a and ∆315–329, but not RR340;531, enhanced 
the activity of β-catenin in the TOPFlash luciferase assay in A549 cells. Firefly luciferase activity was normalized to the 
activity of Renilla luciferase. (I) Western blot, showing coimmunoprecipitation of Flag-Fam13a and myc-axin. Of note, we 
did not detect any interaction between Flag-Fam13a and myc-GSK3β. (J) Western blot showing that overexpression of 
Fam13a reduced the expression of HA-Axin in A549 cells. The expression level of myc-GSK3ß was not altered by 
Fam13a overexpression.
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viduals carrying FAM13A risk SNPs may have a more robust Wnt 
activation in response to cigarette smoke or other harmful inhaled 
substances, which increases the susceptibility to lung diseases.
It is also worth noting that Fam13a shuttles between the nucleus 
and cytoplasm. Nuclear localization of Fam13a is important for its 
function in the Wnt pathway. The subcellular distribution of Fam13a 
is influenced by the phosphorylation status on Ser-322. Reversible 
phosphorylation of Ser-322 is controlled by the antagonistic action 
of Akt and B56-containing PP2As. When Ser-322 is phosphorylated 
by Akt, the binding between Fam13a and 14-3-3 is enhanced, lead-
ing to cytoplasmic sequestration of Fam13a. B56-containing PP2As 
function redundantly to dephosphorylate Fam13a and promote 
nuclear localization of Fam13a. Identification of Fam13a as a target 
of Akt and B56-containing PP2As is of particular interest. It is well 
known that Akt is involved in a wide range of diseases, including 
cancers (Franke, 2008). Aberrant Akt signaling has been docu-
mented in many human lung diseases, ranging from COPD to lung 
cancers (David et al., 2004; Bozinovski et al., 2006). In addition, mu-
tations in B56γ (Shouse et al., 2010) and the β isoform of PP2A A 
subunit (Wang et al., 1998) have been identified from lung cancer 
patients. It is possible that due to mutations in PP2A or perturbation 
of Akt under disease conditions, Fam13a becomes mislocalized. 
This alters the function of Fam13a, which contributes to lung patho-
logical conditions. Further work is needed to test this hypothesis.
In summary, our results demonstrate that Akt and B56-containing 
PP2As regulate Ser-322 phosphorylation of Fam13a. The phosphory-
lation status of Ser-322 influences the binding between Fam13a and 
14-3-3 and determines the subcellular localization of Fam13a. We 
provide evidence that nuclear localization of Fam13a is required for 
its function in the Wnt pathway. Although Fam13a is not essential for 
Wnt signaling under normal conditions, knockdown of Fam13a signif-
icantly reduces the Wnt signaling activity in A549 human lung cancer 
cells. Our work provides important clues to elucidating the mecha-
nism by which Fam13a may contribute to human lung diseases.
MATERIALS AND METHODS
Yeast two-hybrid screen
An adult mouse brain cDNA library (Clontech, Palo Alto, CA) was 
screened using full-length Xenopus B56ε (pGBKT-B56ε) or mouse 
Fam13a (pGBKT-Fam13a) as bait, according to standard protocols 
(Yeast Protocols Handbook; Clontech).
Plasmids
The full-length and all deletion constructs of mouse Fam13a 
and mouse 14-3-3η and 14-3-3ε expression constructs were gen-
erated by standard cloning methods. B56 expression constructs 
were described previously (Jin et al., 2009, 2011). Fam13a NLS 
mutants (RR340AA, RR531AA, and RR340; 531AA), S322A, and 
∆315–329;T411A were generated by site-directed mutagenesis. 
Cloning details will be provided upon request.
Cell culture, transfection, and inhibitor treatments
NIH3T3, HEK293T, PC6-3, and A549 cells were cultured and trans-
fected as described (Strack et al., 2004; Jin et al., 2010). siRNA-medi-
ated knockdown of endogenous B56ε in NIH3T3 or knockdown of 
endogenous Fam13a in A549 cells was performed using Lipo-
fectamine 2000 transfection reagent (Life Technologies, Gaithersburg, 
MD). The sequences for the sense and antisense strands of siRNAs 
are as follows: siGFP, 5′-gcaagcugacccugaaguucuu-3′; 5′-gaacuucagg-
gucagcuugcuu-3′. siB56ε, 5′-ccuagugacagcaaugaauuu-3′; 5′ -auu-
cauugcugucacuagguu-3′. siFam13a, 5′-ggagaacucuuagaaagaauu-3′; 
5′-uucuuucuaagaguucuccuu-3′. Knockdown of B56s in PC6-3 cells 
It appears that Fam13a is dispensable for Wnt signaling in normal 
lungs but contributes to the activation of the Wnt pathway in human 
lung cancer cells.
DISCUSSION
Recent GWASs demonstrate that the FAM13A gene is associated 
with multiple human lung diseases, including COPD, asthma, lung 
cancer, and pulmonary fibrosis (Cho et al., 2010; Hancock et al., 
2010; Pillai et al., 2010; Young et al., 2011; Fingerlin et al., 2013). In 
the case of COPD, the risk allele is associated with elevated expres-
sion of FAM13A in the lung (Kim et al., 2014), suggesting that in-
creased expression of Fam13a may have an important contribution 
to human lung pathological conditions. The biological function of 
Fam13a has been completely unknown.
Our results provide important clues to elucidate mechanisms 
through which Fam13a may contribute to human lung diseases. We 
show that FAM13A-knockout mice are viable and healthy. The 
FAM13A mutant lungs are morphologically indistinguishable from 
wild-type controls. Thus Fam13a is dispensable for embryonic and 
postnatal lung development. It is also not an essential gene for 
normal function of the lung in adult animals.
Whereas Fam13a is dispensable under normal conditions, our 
results reveal that Fam13a is capable of activating Wnt signaling. 
We show that Fam13a acts in the nucleus to regulate Wnt signaling. 
Consistent with this result, we failed to detect an interaction be-
tween Fam13a and GSK3ß, a key component of the β-catenin de-
struction complex. These observations argue against a direct role of 
Fam13a in the β-catenin destruction complex. Of interest, Fam13a 
interacts with axin and regulates its stability. Axin is a nuclear–cyto-
plasmic shuttling protein (Cong and Varmus, 2004; Wiechens et al., 
2004). It is possible that Fam13a regulates posttranslational of 
modification(s) of axin in the nucleus, leading to axin turnover. By 
promoting axin turnover, Fam13a indirectly increases the stability of 
β-catenin, which ultimately results in Wnt activation. In agreement 
with this view, we found that overexpression of Fam13a in Xenopus 
embryos activates the expression of Wnt target genes, including 
Xnr3 and siamois, and triggers the formation of secondary axis. In 
A549 cells, overexpression of Fam13a induces TOPFlash, a Wnt lu-
ciferase reporter. Conversely, depletion of Fam13a in A549 human 
lung cancer cells or knockout of the mouse FAM13A gene leads to 
a reduction in Wnt signaling activity, judged by decreased transcrip-
tion of axin2, a direct target of Wnt signaling (Jho et al., 2002). Of 
note, we observed only a subtle reduction in axin2 transcription in 
FAM13A-knockout lungs, indicating that Fam13a is largely dispens-
able for Wnt signaling under normal conditions. By contrast, a much 
more obvious reduction in axin2 transcription was detected when 
Fam13a was depleted in A549 cells. This suggests that Fam13a 
makes a more important contribution to Wnt signaling in human 
lung cancer cells.
The canonical Wnt pathway plays critical roles in many adult stem 
cells and is important for tissue homeostasis in a wide rang of lin-
eages (Reya and Clevers, 2005). In adult lungs, most Wnt pathway 
components are expressed (Winn et al., 2005; Konigshoff et al., 
2008). Cigarette smoke, the major cause of many human lung dis-
eases, activates the Wnt pathway in bronchial epithelial cells 
(Lemjabbar-Alaoui et al., 2006; Liu et al., 2010). Increased Wnt signal-
ing can lead to severe consequences in the lung (Stewart, 2014). In 
the case of lung cancer, although activation of the Wnt pathway alone 
is insufficient for triggering lung tumorigenesis, when Wnt signaling is 
activated in mice carrying an oncogenic Kras, it induces a much more 
aggressive lung tumor growth (Sidhu et al., 2010). Thus it is possible 
that due to elevated expression of FAM13A (Kim et al., 2014), indi-
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Histological analysis and immunofluorescence
Mouse lungs were inflated, fixed with 4% paraformaldehyde (PFA) 
overnight at 4°C, washed with PBS, and processed for paraffin em-
bedding according to standard protocols. Sections were cut at 5 μm 
and stained with hematoxylin and eosin.
For immunostaining, transfected cells were fixed in 4% PFA for 
30 min and washed with PBS. Cells were incubated in blocking buf-
fer (1% normal goat serum, 1% bovine serum albumin, 0.1% Triton, 
PBS) for 30 min at room temperature, followed by incubation with 
an anti-myc antibody (1:500) overnight at 4°C. Cells were washed 
with PBS and incubated in Alexa Fluor 488xconjugated anti-mouse 
antibody (1:500; #A11029; Life Technologies) for 30 min at room 
temperature. Cells were then washed with PBS and mounted on 
slides. For the subcellular localization analysis, a minimum of 
100 cells were counted for each sample.
Generation and analysis of FAM13A-knockout mice
FAM13A-targeted embryonic stem cells (ES cells; KOMP Reposi-
tory [www.komp.org]) in which exon 5 of the FAM13A gene was 
flanked by LoxP sites were used for blastocyst injection (performed 
by the Transgenic Core Facility at the Research Institute at Nation-
wide Children′s Hospital, Columbus, OH). Male chimeras were 
bred with wild-type C57BL6 females for germline transmission. 
Germline-transmitted mice were then bred sequentially with the 
ACT-FLPe (Jackson Laboratory, Bar Harbor, ME) and Sox2-Cre 
(Jackson Laboratory) mice to delete the neo-cassette and exon 5 
of the FAM13A gene, respectively. Heterozygous mice carrying 
the knockout allele were intercrossed to generate homozygous 
FAM13A knockout mice. Primers for genotyping were as follows: 
wild type forward (WT-F), 5′-gtagtgatgaaggcagagaactg-3′; geno-
typing backward (GT-B), 5′-ggtaaatgaaagggactgcatg-3′; and 
knockout allele forward, (KO-F), 5′-acacacacacatatatattccattc-
tag-3′. WT-F and GT-B were used for the wild-type allele. KO-F and 
GT-B were used for the knockout allele. Primers used for amplifica-
tion of FAM13A mRNA were 5′-tcacaggaagatgaaagacct-3′ and 
5′-ctgtcccccaggttctatgc-3′.
was carried out as described (Strack et al., 2004; Jin et al., 2011). For 
PP2A and Akt inhibition studies, NIH3T3 cells were treated with 
okadaic acid (50 nM, #O7885; Sigma-Aldrich, St. Louis, MO) and/or 
wortmannin (2 μM, #W1628; Sigma-Aldrich) or LY294002 (#L9908; 
Sigma-Aldrich) in DMEM supplemented with 0.5% bovine calf serum 
1 d after transfection and harvested 15 h after drug administration. 
For leptomycin B treatment, NIH3T3 cells were exposed to 5 ng/ml 
leptomycin B (#L2913; Sigma-Aldrich) and/or 50 nM okadaic acid for 
15 h before fixation.
Subcellular fractionation
A549 cells were washed twice with ice-cold phosphate-buffered sa-
line (PBS) and scraped into hypotonic buffer containing 10 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; pH 7.9), 
1.5 mM MgCl2, 1 mM EDTA, 10 mM KCl, 0.5 mM dithiothreitol 
(DTT), and protease inhibitor cocktail. After incubating on ice for 
10 min, cells were centrifuged at 13,000 rpm for 5 min, and the su-
pernatant was collected as the cytosol fraction. The pellets were 
dissolved in a buffer containing 20 mM HEPES (pH 7.9), 1.5 mM 
MgCl2, 1 mM EDTA, 420 mM NaCl, 25% glycerol, 0.5 mM DTT, and 
protease inhibitor cocktail. After incubation on ice for 20 min, the 
sample was centrifuged at 13,000 rpm for 5 min, and the superna-
tant was collected as the nucleus fraction.
Coimmunoprecipitation, GST pull down, Western blots, 
and luciferase assay
Coimmunoprecipitation and Western blots were performed as de-
scribed (Rorick et al., 2007; Jin et al., 2009). For GST pull down, 
cell lysates were incubated with glutathione beads (#17-0756-01; 
GE Healthcare, Waukesha, WI) that were immobilized with bacteri-
ally expressed GST–14-3-3. Proteins associated with beads were 
washed extensively, eluted, and analyzed by Western blot. Anti-
bodies used were as follows: anti-Fam13a (1:400; #HPA038109; 
Sigma-Aldrich), anti-myc (9E10; 1:2000; #5546; Sigma-Aldrich), 
anti-FLAG (M2, 1:1000; #F1804; Sigma-Aldrich), anti-HA (1:1000; 
#H9658; Sigma-Aldrich), anti-B56ε (1:400; Jin et al., 2009), anti–β-
tubulin (1:1000, #T5293; Sigma-Aldrich) and anti-C/EBPβ (1:400; 
#sc-150; Santa Cruz Biotechnology, Santa Cruz, CA). Custom 
anti-pSer-322 antibody was generated by immunizing rabbits 
with a synthesized peptide (Ac-CFMRRRSS(pS)LG-amide) and 
subsequent phosphopeptide affinity purification (New England 
Peptide, Gardner, MA). TOPFlash luciferase reporter assay was 
performed as described (Veeman et al., 2003; Jin et al., 2011).
RNA extraction, RT-PCR, and PCR purification
RNA purification and RT-PCR were performed as described (Yang 
et al., 2003). Primers for analyzing FAM13A expression in adult mouse 
tissues were 5′-cctgaggacattaaggatatga-3′ and 5′-tggagggggaac-
caatgatg-3′. Primers for Xnr3, siamois, noggin, sizzled, sox17, ODC 
(Yang et al., 2003; Mei et al., 2013), chordin, and Xbra have been 
described (Rorick et al., 2007). Quantitative real-time PCR was per-
formed as described (Jin et al., 2011). Primers were as follows: human 
axin2, 5′-cctgccaccaagacctacat-3′ and 5′-cttcattcaaggtggggaga-3′; 
human β-actin, 5′-agcgggaaatcgtgcgtgac-3′ and 5′-caatggtgat-
gacctggccgt-3′; mouse axin2, 5′-cagcccttgtggttcaagcttc-3′ and 
5′-ggtagattcctgatggccgtagt-3′; and mouse β-actin, 5′-agagggaaa-
tcgtgcgtgac-3′ and 5′-caatagtgatgacctggccgt-3′.
Xenopus embryos and manipulations
Xenopus embryos were obtained as described (Sive et al., 2000). 
Microinjection and animal cap assays were performed as described 
(Sive et al., 2000).
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